The results indicate that the expression level of MTMR2 is a prognostic factor for ACC, BLCA, BRCA, CESC, GBM, KIRC, LIHC, LUAD, PAAD, SARC, and THYM (p < 0.05) (Fig. 1B). This evidence concerns the gene MTMR2 and bladder transitional cell carcinoma.